Literature DB >> 4641855

A neutrophil-immobilizing factor derived from human leukocytes. I. Generation and partial characterization.

E J Goetzl, K F Austen.   

Abstract

A factor has been derived from human leukocytes which irreversibly inhibits the response of human neutrophils to diverse chemotactic stimuli without impairing their viability. It is released by both polymorphonuclear and mononuclear leukocytes during incubation in acidic medium, after endotoxin exposure and subsequent incubation in low potassium medium, and during phagocytosis of particles. It is extractable from both leukocyte types and therefore must be preformed. This chemotactic inhibitor is completely separable from contaminating chemotactic activity in the crude supernatants, has a mol wt of 5000, and is inactivated by digestion with trypsin or chymotrypsin. It has been termed a neutrophil-immobilizing factor because it inhibits neutrophils directly and independently of the chemotactic stimulus, and has relatively little effect on human monocyte chemotaxis.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4641855      PMCID: PMC2139334          DOI: 10.1084/jem.136.6.1564

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  28 in total

1.  The monovalent cation content and adenosine triphosphatase activity of human normal and leukemic granulocytes and lymphocytes: relationship to cell volume and morphologic age.

Authors:  M A Lichtman; R I Weed
Journal:  Blood       Date:  1969-11       Impact factor: 22.113

2.  Impaired leucotactic responsiveness in a child with recurrent infections.

Authors:  P A Ward; R J Schlegel
Journal:  Lancet       Date:  1969-08-16       Impact factor: 79.321

3.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

4.  Mediators of inflammation in leukocyte lysosomes. VII. Observations on mast cell-rupturing agents in different species.

Authors:  J Scherer; A Janoff
Journal:  Lab Invest       Date:  1968-02       Impact factor: 5.662

5.  Complement dependent immune phagocytosis. I. Requirements for C'1, C'4, C'2, C'3.

Authors:  I Gigli; R A Nelson
Journal:  Exp Cell Res       Date:  1968-07       Impact factor: 3.905

6.  Inhibitor of macrophage migration produced by polymorphonuclear leucocytes.

Authors:  P Stastny; M Ziff
Journal:  J Reticuloendothel Soc       Date:  1970-01

7.  The chemotactic activity for neutrophil and eosinophil leucocytes of the trimolecular complex of the fifth, sixth and seventh components of human complement (C567) prepared in free solution by the 'reactive lysis' procedure.

Authors:  P J Lachmann; A B Kay; R A Thompson
Journal:  Immunology       Date:  1970-12       Impact factor: 7.397

8.  Chemotoxis of mononuclear cells.

Authors:  P A Ward
Journal:  J Exp Med       Date:  1968-11-01       Impact factor: 14.307

9.  The deactivation of rabbit neutrophils by chemotactic factor and the nature of the activatable esterase.

Authors:  P A Ward; E L Becker
Journal:  J Exp Med       Date:  1968-04-01       Impact factor: 14.307

10.  Isolation and characterization of permeability factors from rabbit neutrophils.

Authors:  N S Ranadive; C G Cochrane
Journal:  J Exp Med       Date:  1968-10-01       Impact factor: 14.307

View more
  62 in total

1.  Proceedings. Site of action of an anti-inflammatory fraction from normal human plasma.

Authors:  J K Badcock; A W Ford-Hutchinson; M J Smith
Journal:  Br J Pharmacol       Date:  1975-06       Impact factor: 8.739

2.  Chemotactic activity derived from interaction of factors D and B of the properdin pathway with cobra venom factor or C3B.

Authors:  S Ruddy; K F Austen; E J Goetzl
Journal:  J Clin Invest       Date:  1975-03       Impact factor: 14.808

3.  Specificity and cellular distribution of human polymorphonuclear leucocyte receptors for leukotriene C4.

Authors:  L Baud; C H Koo; E J Goetzl
Journal:  Immunology       Date:  1987-09       Impact factor: 7.397

4.  Modulation of the inflammatory response by products released from human polymorphonuclear leukocytes during phagocytosis : Generation and inactivation of the chemotactic factor C5a.

Authors:  D G Wright; J I Gallin
Journal:  Inflammation       Date:  1975-03       Impact factor: 4.092

5.  Cold urticaria. Recognition and characterization of a neutrophil chemotactic factor which appears in serum during experimental cold challenge.

Authors:  S I Wasserman; N A Soter; D M Center; K F Austen
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

6.  A proposal for the definition of terms related to locomotion of leucocytes and other cells.

Authors:  H U Keller; P C Wilkinson; M Abercrombie; E L Becker; J G Hirsch; M E Miller; W Scottramsey; S H Zigmond
Journal:  Clin Exp Immunol       Date:  1977-03       Impact factor: 4.330

7.  Alterations in human leukocyte function induced by ingestion of eicosapentaenoic acid.

Authors:  D G Payan; M Y Wong; T Chernov-Rogan; F H Valone; W C Pickett; V A Blake; W M Gold; E J Goetzl
Journal:  J Clin Immunol       Date:  1986-09       Impact factor: 8.317

8.  A phagocytosis-enhancing factor in human plasma.

Authors:  I Gigli; B U Wintroub; E J Goetzl
Journal:  Immunology       Date:  1976-06       Impact factor: 7.397

9.  In vitro correlates of delayed hypersensitivity in man: ambiguity of polymorphonuclear neutrophils as indicator cells in leukocyte migration test.

Authors:  G Senyk; W K Hadley
Journal:  Infect Immun       Date:  1973-09       Impact factor: 3.441

10.  Role of secretory events in modulating human neutrophil chemotaxis.

Authors:  J I Gallin; D G Wright; E Schiffmann
Journal:  J Clin Invest       Date:  1978-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.